Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler

[1]  P. Brugières,et al.  [Transcranial color Doppler in children with sickle cell disease]. , 2003, Journal de radiologie.

[2]  E. Butcher,et al.  Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity , 2002 .

[3]  G. Sebag,et al.  Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation , 2000, Journal of child neurology.

[4]  R. Ware,et al.  Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease , 1999 .

[5]  Scott T. Miller,et al.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.

[6]  R. Adams,et al.  Long‐term stroke risk in children with sickle cell disease screened with transcranial doppler , 1997, Annals of neurology.

[7]  D. Labie,et al.  Three-Year Follow-Up of Hydroxyurea Treatment in Severely Ill Children with Sickle Cell Disease , 1997 .

[8]  P. Brugières,et al.  Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: correlation with MRI, MRA and conventional angiography , 1995, Pediatric Radiology.

[9]  M L Terrin,et al.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.

[10]  R. Adams,et al.  Transcranial Doppler Correlation With Cerebral Angiography in Sickle Cell Disease , 1992, Stroke.

[11]  R. Adams,et al.  The use of transcranial ultrasonography to predict stroke in sickle cell disease. , 1992, The New England journal of medicine.

[12]  P.,et al.  A Cautionary Note Regarding Hydroxyurea in Sickle Cell Disease , 2002 .

[13]  D. Labie,et al.  Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. , 1997, Journal of pediatric hematology/oncology.

[14]  S. Lemerle,et al.  Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO. , 1993, Bone marrow transplantation.

[15]  M. Reivich,et al.  Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. , 1984, Blood.